0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Fibromyalgia -Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-138
Home | Market Reports | Health | Health Conditions
Fibromyalgia Epidemiology Forecast to 2028

Fibromyalgia -Epidemiology Forecast to 2028

Code: DELV-Epid-138
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Fibromyalgia  - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Fibromyalgia  epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Fibromyalgia  Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Fibromyalgia  in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Fibromyalgia  outlook. It also includes the explanation of changing trends of epidemiology outlining the Fibromyalgia  scenario.

Fibromyalgia  Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Fibromyalgia  thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Fibromyalgia  explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Fibromyalgia  Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Fibromyalgia 

Key assessments
• Patient Segmentation in Fibromyalgia 
• Fibromyalgia  Risk & Burden
• Factors driving growth in a specific Fibromyalgia  patient population

1. Report Introduction
2. Fibromyalgia  Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Fibromyalgia  in 2016
2.2. Patient Share Distribution of Fibromyalgia  in 2028
3. Disease Background and Overview: Fibromyalgia 
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Fibromyalgia  in 7MM
4.3. Total Prevalent/ Incident Patient Population of Fibromyalgia  in 7MM – By Countries
5. Epidemiology of Fibromyalgia  by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Fibromyalgia 
5.1.3. Sub-Type Specific cases of the Fibromyalgia  *
5.1.4. Sex- Specific Cases of the Fibromyalgia *
5.1.5. Diagnosed Cases of the Fibromyalgia 
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Fibromyalgia 
5.4.3. Sub-Type Specific cases of the Fibromyalgia *
5.4.4. Sex- Specific Cases of the Fibromyalgia *
5.4.5. Diagnosed Cases of the Fibromyalgia 
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Fibromyalgia 
5.5.3. Sub-Type Specific cases of the Fibromyalgia *
5.5.4. Sex- Specific Cases of the Fibromyalgia *
5.5.5. Diagnosed Cases of the Fibromyalgia 
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Fibromyalgia 
5.6.3. Sub-Type Specific cases of the Fibromyalgia *
5.6.4. Sex- Specific Cases of the Fibromyalgia *
5.6.5. Diagnosed Cases of the Fibromyalgia 
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Fibromyalgia 
5.7.3. Sub-Type Specific cases of the Fibromyalgia *
5.7.4. Sex- Specific Cases of the Fibromyalgia *
5.7.5. Diagnosed Cases of the Fibromyalgia 
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Fibromyalgia 
5.8.3. Sub-Type Specific cases of the Fibromyalgia *
5.8.4. Sex- Specific Cases of the Fibromyalgia *
5.8.5. Diagnosed Cases of the Fibromyalgia 
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Fibromyalgia 
5.9.3. Sub-Type Specific cases of the Fibromyalgia *
5.9.4. Sex- Specific Cases of the Fibromyalgia *
5.9.5. Diagnosed Cases of the Fibromyalgia 
6. Unmet Needs of the Fibromyalgia 
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Fibromyalgia  in 7MM
Table 2: Total Prevalent/Incident Cases of the Fibromyalgia  in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Fibromyalgia  in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Fibromyalgia  in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Fibromyalgia  in United States (2016-2028)*
Table 6: Diagnosed Cases of the Fibromyalgia  in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Fibromyalgia  in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Fibromyalgia  in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Fibromyalgia  in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Fibromyalgia  in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Fibromyalgia  in France (2016-2028)
Table 12: Sub-Type Specific cases of the Fibromyalgia  in France (2016-2028) *
Table 13: Sex- Specific Cases of the Fibromyalgia  in France (2016-2028) *
Table 14: Diagnosed Cases of the Fibromyalgia  in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Fibromyalgia  in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Fibromyalgia  in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Fibromyalgia  in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Fibromyalgia  in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Fibromyalgia  in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Fibromyalgia  in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Fibromyalgia  in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Fibromyalgia  in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Fibromyalgia  in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Fibromyalgia  in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Fibromyalgia  in UK (2016-2028) *
Table 26: Diagnosed Cases of the Fibromyalgia  in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Fibromyalgia  in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Fibromyalgia  in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Fibromyalgia  in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Fibromyalgia  in Japan (2016-2028)

List of Figures :

Figure 1: Total Prevalent/Incident Cases of the Fibromyalgia  in 7MM
Figure 2: Total Prevalent/Incident Cases of the Fibromyalgia  in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Fibromyalgia  in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Fibromyalgia  in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Fibromyalgia  in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Fibromyalgia  in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Fibromyalgia  in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Fibromyalgia  in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Fibromyalgia  in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Fibromyalgia  in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Fibromyalgia  in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Fibromyalgia  in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Fibromyalgia  in France (2016-2028) *
Figure 14: Diagnosed Cases of the Fibromyalgia  in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Fibromyalgia  in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Fibromyalgia  in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Fibromyalgia  in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Fibromyalgia  in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Fibromyalgia  in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Fibromyalgia  in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Fibromyalgia  in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Fibromyalgia  in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Fibromyalgia  in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Fibromyalgia  in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Fibromyalgia  in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Fibromyalgia  in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Fibromyalgia  in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Fibromyalgia  in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Fibromyalgia  in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Fibromyalgia  in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

China Diclofenac Sodium and Codeine Phosphate Tablets Market Report Forecast 2021 2027
China Diclofenac Sodium and Codeine Phosphate Tablets Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-23N6694
Tue Oct 26 00:00:00 UTC 2021

Add to Cart

Global and Japan Diabetic Eye Disease Devices Market Insights Forecast to 2027
Global and Japan Diabetic Eye Disease Devices Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-2A7205
Mon Oct 25 00:00:00 UTC 2021

Add to Cart

China Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Report Forecast 2021 2027
China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-18X6955
Mon Oct 25 00:00:00 UTC 2021

Add to Cart

China Cardiovascular and Cerebrovascular API Market Report Forecast 2021 2027
China Cardiovascular and Cerebrovascular API Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-30A6653
Mon Oct 25 00:00:00 UTC 2021

Add to Cart